TAK-242

· Akaza Bioscience Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-242, covering 2021-08-02 to 2021-08-02. Get the full timeline:

Most recent: Clinical Trial Update: TAK-242 in Patients With Acute Alcoholic Hepatitis [Phase 2]